ArticleBMC cancer2016
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
Jonghoon Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleBMC cancer2016
Jonghoon Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.